AIScience

New AI Framework Overcomes Critical Hurdle in Drug Discovery Pipeline

A scientist has developed a novel deep learning framework that tackles one of the most persistent challenges in AI-powered drug discovery. The approach focuses specifically on improving how models generalize to new protein families and chemical structures they haven’t encountered during training.

Breaking the Generalization Barrier in AI Drug Discovery

Researchers are reporting a potential breakthrough in applying machine learning to the earliest stages of drug discovery, addressing a critical limitation that has hampered real-world implementation. According to sources familiar with the research, a new framework specifically targets the “generalizability gap” that causes AI models to fail unpredictably when encountering unfamiliar chemical structures.

BusinessManufacturing

DuPont Receives Buy Rating Ahead of Electronics Division Spinoff, Investment Strategy Revealed

DuPont has reportedly received a short-term catalyst buy rating from Deutsche Bank analysts ahead of its November electronics division spinoff. According to investment club sources, the plan is to hold both DuPont and the new Qnity Electronics shares due to significant valuation discounts compared to industry peers.

Analysts Bullish on DuPont Ahead of Corporate Restructuring

Chemical giant DuPont has been named a short-term catalyst buy idea by Deutsche Bank analysts, according to recent reports from the CNBC Investing Club. The positive rating comes ahead of the company’s planned November 1 spinoff of its electronics division, which will operate as a separate entity called Qnity Electronics.